Categories: Health

VALNEVA Declaration of shares and voting rights: January 31, 2026

VALNEVA

Declaration of shares and voting rights
January 31, 2026
__________________________________________________________________________________________

Company name: VALNEVA
Registered office: Îlot Saint-Joseph Bureaux Convergence – Bât. A, 12 ter Quai Perrache – 69002 Lyon
Regulated market of Euronext Paris – Compartment B

Declaration date: February 6, 2026

Number of shares
composing the share capital of Valneva
Total number of voting rights including suspended voting rights* Description of the change Date on which this change was recognized Total number of voting rights excluding suspended voting rights**
 

173,877,420

ordinary shares with a par value of €0.15 each

189,607,235 Double voting rights granted on 890 ordinary shares

Transfer into bearer form of 159,714 shares with double voting rights

Exercise of stock options resulting in the issuance of 337,675 new ordinary shares

Between January 8 & January 30, 2026

On January 9, 2026

Between January 12 & January 30, 2026

189,482,913

___________________________

* Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.
** Net (or exercisable at a General Meeting) voting rights.

GlobeNews Wire

Recent Posts

NYSE Content Update: ‘Patty’ at Center of Burger King’s New BK Assistant AI Solution

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 26, 2026…

4 hours ago

Hettich to Unveil New Innovations at Indiawood 2026, Showcasing Its Vision for Future Living and Workspaces

As industry leaders and design professionals gear up for Indiawood 2026, Hettich is preparing to…

4 hours ago

weBoost Named Winner in 2026 Merit Awards for Telecom & Wireless

ST. GEORGE, Utah, Feb. 26, 2026 (GLOBE NEWSWIRE) -- weBoost, the leader in cell signal…

5 hours ago

Ataccama Launches Agentic Data Observability to Extend Market-Leading Data Trust Platform

BOSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Ataccama, the data trust company, today announced Agentic…

5 hours ago

Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated with FT819 off-the-shelf…

5 hours ago